Advance to reserve U.S. test capacity
$1.1B
Announced Oct 21, 2026; high-volume production targeted for April 2027
Supply and capacity commitments
$279B
As of July 26, 2026, up from $119 billion on April 26, 2026
Its own capital spending
2.4% of revenue
$7.35 billion spent in the twelve months to July 26, 2026, against $134.4 billion of operating cash flow
Test capacity it expects to secure
2x
Calendar 2026 to 2027, across buildouts in the U.S., Taiwan and Singapore
The announcement
One Advance, Six Suppliers: NVIDIA Starts Buying Capacity Instead of Order Book
NVIDIA stopped waiting for its back-end suppliers to finance the AI buildout. On October 21, 2026 it announced six capacity agreements spanning substrates, advanced packaging, chip test and co-packaged optics, including two explicit cash advances: $1.1 billion to King Yuan Electronics to reserve U.S. test capacity, and a multibillion-dollar advance to fund IBIDEN's Ono Plant in Japan. The King Yuan line targets high-volume production in April 2027, with expanded Singapore test operations due to start high-volume output in February 2027.
| Partner | Layer | What NVIDIA committed | Capacity target and timing |
|---|---|---|---|
| King Yuan Electronics (Taipei-listed) | Back-end chip test | $1.1 billion capacity reservation advance; disclosed ceiling of up to NT$45 billion | New U.S. testing facilities and equipment; high-volume production April 2027 |
| Amkor Technology | Advanced packaging | New $1.3 billion agreement; $3 billion of multi-year agreements with NVIDIA across Arizona and South Korea | More than 300% interposer wafer capacity by end-2028 |
| IBIDEN | ABF substrate | Multibillion-dollar capacity reservation advance | 3x current capacity at the Ono Plant; additional capacity ramps from Q1 2028 |
| Samsung Electro-Mechanics | ABF substrate | Co-investment in dedicated AI substrate lines at Sejong and Busan | Multiyear supply from 2026; NVIDIA-related output a significant share of capacity by 2028 |
| Siliconware Precision Industries (ASE Technology Holding group) | Co-packaged optics | Named partner in the optical-engine expansion | 15x optical-engine capacity by mid-2027, roughly 30x by end-2028 |
| Unimicron Technology | Substrate | Named partner in the substrate expansion | Supporting NVIDIA's 2.5x substrate capacity target over three years |
- Testing doubles first: NVIDIA expects total semiconductor test capacity to double from calendar 2026 to 2027 across the United States, Taiwan and Singapore.
- Substrates follow: NVIDIA plans to increase substrate capacity for its own products 2.5x over three years, with IBIDEN, Samsung Electro-Mechanics and Unimicron Technology among the named partners.
- Advanced packaging is the longest build: Amkor Technology targets more than 300% interposer wafer capacity by the end of 2028.
- Optics is the fastest riser: Siliconware Precision Industries' optical-engine capacity is targeted at 15x by mid-2027, then another doubling by the end of 2028.
The balance sheet behind the check
The Number That Matters Is $279 Billion, Not $1.1 Billion
NVIDIA's supply and capacity commitments, US$ billions
As disclosed in NVIDIA's Form 10-Q filings. The commitments now equal roughly 92% of trailing revenue of $303.0 billion and 2.8x the $99.4 billion of cash and short-term investments held at July 26, 2026.
Unit: US$ billions
Commitments, Apr 26, 2026
$95 billion due to be paid in the remainder of fiscal2027
119
Commitments, Jul 26, 2026
Latest disclosed figure, quarter ended July 26, 2026
279
The advance to the test line is the small, visible end of a much larger shift. NVIDIA's supply and capacity commitments rose from $119 billion at the end of April — of which $95 billion was due to be paid in the remainder of fiscal 2027 — to $279 billion at the end of July, and the increase was reported as driven mainly by memory procurement. That is what makes the test advance interesting: the same structure quietly funding memory is now reaching the back end of the line, where installation timing rather than design decides how fast chips ship.
Cash and short-term investments
$99.4B
At July 26, 2026, against $279 billion of supply and capacity commitments
Trailing revenue
$303.0B
Twelve months ended July 26, 2026; commitments equal about 92% of it
Trailing operating cash flow
$134.4B
Twelve months ended July 26, 2026
Q2 FY2027 revenue and margin
$96.2B at 75.0%
Quarter ended July 26, 2026; net income $59.7 billion
Balancing that is a cost NVIDIA has already shown it can absorb. A $0.4 billion charge tied to H200 excess inventory and purchase obligations landed in the first half of fiscal 2027, and $985 million of inventory provisions in the June quarter already show how the structure fails when committed product does not sell. Deferred revenue on NVIDIA's balance sheet rose from $3.1 billion at the end of April to $9.6 billion at the end of July, though the filings do not break out how much of that relates to capacity prepayments.
Who carries the assets
The Vendors Now Hold the Cycle on Their Own Balance Sheets
King Yuan Electronics is the clearest case, and it is not a healthy one. The Taipei-listed test house raised its 2026 capital budget to NT$50 billion from NT$39.4 billion in May, weighted toward high-power burn-in and advanced packaging test, and on a trailing basis it spends 74% of revenue on capacity: NT$29.98 billion of capital expenditure against NT$16.75 billion of operating cash flow, leaving free cash flow at minus NT$13.2 billion and NT$16.5 billion of new net debt issued over the period. A capital budget that exceeds a full year of revenue is what customer prepayments look like from the inside.
The pattern repeats elsewhere at different intensities. ASE Technology Holding, whose wholly owned packaging unit Siliconware Precision Industries NVIDIA named for the optical-engine buildout, runs trailing capital spending at 28.8% of revenue, with trailing free cash flow to the firm of minus NT$28.3 billion and net debt at 1.33x EBITDA; the group said in June 2026 it was expanding capacity to support AI demand. Samsung Electro-Mechanics spent ₩1.62 trillion against ₩1.83 trillion of operating cash flow over the trailing twelve months, and IBIDEN reinvested essentially all of its fiscal 2026 operating cash flow into capacity while still holding net cash.
Amkor Technology net sales, US$ billions
The payoff at the packaging line: revenue accelerating while gross margin recovers, with advanced products at $1.557 billion of the $1.898 billion reported for the June 2026 quarter.
Unit: US$ billions
Q2 2025
Comparison figure in the second-quarter 2026 release
1.5
Q2 2026
Gross margin of 16.8%, up from 14.2% in Q1 2026
1.9
Q3 2026 guidance midpoint
Guidance of $1.95–2.05 billion at an 18.5–19.5% gross margin
2
| Layer | Source of funding | Size and mechanism | What the vendor takes on |
|---|---|---|---|
| Back-end test | NVIDIA, via customer prepayment | $1.1 billion advance to King Yuan Electronics; disclosed ceiling of up to NT$45 billion | Not revenue — offset against future testing fees; the vendor still funds the plant and the testers |
| Advanced packaging | NVIDIA, via multi-year agreements | $1.3 billion new agreement; $3 billion of multi-year agreements with Amkor Technology | Fiscal 2026 capital spending of $2.5–3.0 billion lands before the revenue |
| ABF substrate | NVIDIA, via capacity reservation advance and co-investment | Multibillion-dollar advance to IBIDEN; co-investment at Samsung Electro-Mechanics's Sejong and Busan plants | About ¥280 billion of planned investment at the Ono Plant; customer-backed expansion in Korea |
| Co-packaged optics | NVIDIA, through the packaging partners | Siliconware Precision Industries named in a 15x optical-engine expansion | Capacity has to be installed and qualified by mid-2027 |
Upstream of the test line
The Tool Makers Get Paid for the Same Buildout
Every tester, handler and prober bought for those lines is a separate revenue stream, and the equipment makers' order books confirm the capacity buildout is real rather than announced. Advantest raised its fiscal 2027 forecast on July 29, 2026 to sales of ¥1,714 billion from ¥1,420 billion and operating income of ¥846 billion, said test demand for inference AI semiconductors is now expected to significantly exceed its own April projections, and is expanding production capacity ahead of schedule. Teradyne's semiconductor test revenue of $1,122 million in the June quarter more than doubled year over year, lifting group revenue 104% to $1,329 million at a 59.8% gross margin.
Advantest fiscal 2027 forecast, ¥ billions
Advantest's raised fiscal 2027 forecast, including ¥50 billion of capital spending as it expands capacity ahead of schedule.
Unit: ¥ billions
Sales forecast, Apr 2026
Forecast published with the April 2026 results
1,420
Sales forecast, Jul 2026
Raised forecast published Jul 29, 2026
1,714
Operating income forecast, Jul 2026
Implies a 47.3% operating margin
846
- Upstream of the test line: Advantest and Teradyne supply the testers; IBIDEN, Samsung Electro-Mechanics and Unimicron Technology supply the substrates that tested packages sit on.
- At the test line: King Yuan Electronics, plus the assembly-and-test plants of Amkor Technology and ASE Technology Holding, turn wafers into qualified AI packages.
- Downstream of the test line: Microsoft and Amazon buy the finished systems, and their capital budgets are what NVIDIA's $279 billion commitment book ultimately rests on.
- The exception to watch: memory. The bulk of the increase in commitments was reported as memory procurement, so the test advance is the visible edge of a much larger financing shift rather than its center.
Downstream of the test line
Microsoft and Amazon Are the Ultimate Financiers
The demand filling NVIDIA's commitment book comes from a very small set of buyers with enormous capital budgets. Microsoft's fiscal 2026 capital spending reached $115.9 billion, up from $64.6 billion a year earlier; Amazon spent $173.0 billion over the trailing twelve months to June 2026, more than its $161.4 billion of operating cash flow, pushing trailing free cash flow to minus $11.6 billion. Neither can fund that pace indefinitely from current cash flow, which is why Microsoft and Amazon are the ultimate financiers of the AI buildout and the vendors have become the intermediate lenders.
Long before the AI models emerge, the infrastructure has to exist.
The geography carries the same message. At GTC Berlin, NVIDIA said it was committing nearly $10 billion to the European technology ecosystem, while the announced buildout places test capacity in the United States and Singapore, advanced packaging in Korea and Arizona, and substrate capacity in Japan. Capacity is no longer only a cost line — it is industrial policy, and the suppliers who own it gain bargaining weight that chip designers do not have.
This is where the structure is most fragile. A prepayment is a promise to buy, and if the buildout slows, the obligation does not shrink with the slowdown: NVIDIA's own first-half fiscal 2027 results include a $0.4 billion charge for H200 excess inventory and purchase obligations and $985 million of inventory provisions in the June quarter. Apply the same treatment to capacity commitments and the vendors who absorbed the financing absorb the write-down, on plants built for a single customer.
Horizons
What Moves in Quarters, and What Compounds for Years
- October 26, 2026: Amkor Technology reports third-quarter results after the close, against guidance of $1.95–2.05 billion of net sales and an 18.5–19.5% gross margin — the first read on whether margin recovery survives the capacity ramp.
- November 2026: NVIDIA's third-quarter fiscal 2027 report, where a third straight jump in supply and capacity commitments would show the financing structure widening rather than one-off.
- February 2027: high-volume production from the expanded Singapore test operations.
- April 2027: high-volume production at the King Yuan Electronics U.S. test line, the first physical proof that prepayments bought usable capacity.
- Q1 2028: additional IBIDEN Ono Plant capacity begins ramping, targeting three times current output.
- End-2028: Amkor Technology targets more than 300% interposer wafer capacity, and Siliconware Precision Industries' optical engines roughly triple again after the mid-2027 step to 15x.
- 2028: NVIDIA-related output is expected to account for a significant share of Samsung Electro-Mechanics's total substrate capacity, making customer funding the dominant source of expansion capital in that business.
The back-end buildout calendar
July 2026
King Yuan board approves prepayment
Approved in July, disclosed October 13
October 13, 2026
Prepayment agreement disclosed
Up to NT$45 billion, via U.S. subsidiary AeternZ
October 21, 2026
NVIDIA announces six agreements
$1.1 billion to King Yuan; $1.3 billion to Amkor
February 2027
Singapore test output starts
High-volume production target
April 2027
U.S. test line starts
King Yuan high-volume production target
Mid-2027
Optical engines at 15x
Siliconware Precision Industries capacity target
Q1 2028
Ono Plant ramp begins
IBIDEN additional capacity
End-2028
Interposer capacity above 300%
Amkor target; optical engines roughly triple
Synthesis
Whoever Owns the Capacity Owns the Cycle
Fact: NVIDIA has committed $279 billion of supply and capacity, prepaid $1.1 billion to reserve U.S. test capacity and told six suppliers to expand. Fact: those suppliers, not NVIDIA, are carrying the fixed assets, with trailing capital spending at 25% to 74% of revenue across the test, packaging and substrate names. Inference: the AI buildout has quietly become a supplier-financed infrastructure project, with NVIDIA as anchor tenant and funder, which relocates the durable profit from the chip designer to the owners of scarce capacity.
Speculation, flagged as such: if commitments keep compounding while test pricing holds, the owners of test and substrate capacity earn a financing spread that did not exist in the previous cycle — customer cash funds assets that keep earning for years. The counter-case is equally concrete: prepayments are contractual obligations against future services, NVIDIA's own results show what happens when committed product does not sell, and a vendor spending 74% of revenue on capacity has no cheap exit if the order book stalls.
- The thesis fails if commitments stop climbing: a flat supply and capacity book next quarter would mark the financing shift as a one-quarter phenomenon.
- It fails if prepayments do not convert: if King Yuan's testing services do not start drawing down the prepayment on schedule for April 2027, the liability simply sits on the balance sheet.
- It fails if vendor leverage rises instead: if test houses fund expansion with debt faster than prepayments arrive — net debt climbing faster than customer cash — thenthe burden has not actually shifted off NVIDIA and onto the supply chain.
Where the financing actually lands
- A $279 billion commitment book, up from $119 billion, now equals about 92% of trailing revenue of $303.0 billion — supply is secured, but the balance sheet carries it.
- Trailing capex of 2.4% of revenue means NVIDIA funds other people's plants rather than its own; it converts supply risk into counterparty risk.
- Next six months: the third-quarter fiscal 2027 report is the test — another jump in NVIDIA's commitments confirms the financing shift is structural, a flat book suggests a one-quarter effect.
- NVIDIA's multi-year agreements now total $3 billion across Arizona and South Korea, with a new $1.3 billion agreement announced October 21, 2026.
- Q3 2026 guidance of $1.95–2.05 billion at an 18.5–19.5% gross margin, up from 16.8% in Q2, shows the capacity ramp already converting into margin.
- Over one to three years the above-300% interposer wafer target by end-2028 is the volume unlock; the risk is FY2026 capital spending of $2.5–3.0 billion arriving first.
- Siliconware Precision Industries, the group's packaging unit that NVIDIA named, targets 15x optical-engine capacity by mid-2027 and roughly 30x by end-2028.
- Trailing capital spending at 28.8% of revenue and negative free cash flow of NT$28.3 billion mean customer prepayments matter more here than at peers.
- Direction turns constructive if advances extend beyond packaging into the group's testing operations, and negative if net debt at 1.33x EBITDA funds capacity without matching customer cash.
- NVIDIA is co-investing in dedicated AI substrate lines at the Sejong and Busan plants, with supply starting in 2026 and double-digit annual volume growth.
- Q2 2026 revenue of ₩3.46 trillion was 24% higher year over year at a 24.1% gross margin, with trailing capital spending of ₩1.62 trillion still covered by operating cash flow.
- By 2028, NVIDIA-related output is expected to be a significant share of total capacity, so customer capital displaces company-funded expansion over one to three years.
- A multibillion-dollar NVIDIA capacity reservation advance funds part of a planned ¥280 billion capital program at the Ono Plant, targeting 3x current output.
- The advance arrives without balance-sheet strain: IBIDEN ended the period with net cash and a 47.8% operating margin in fiscal 2026.
- The ramp starts in Q1 2028, so the volume unlock is a one-to-three-year story while substrate scarcity persists in the meantime.
- The fiscal 2027 forecast jumped to ¥1,714 billion of sales from ¥1,420 billion and ¥846 billion of operating income, pricing in the test expansion now under way.
- Inference-AI test demand is now expected to exceed the company's own April projections, and production capacity is being expanded ahead of schedule.
- Over one to three years, tester content per AI package is the lever; the near-term risk is delivery timing against the April 2027 test-line start.
- Semiconductor test revenue of $1,122 million in Q2 2026 more than doubled year over year, lifting group revenue 104% to $1,329 million at a 59.8% gross margin.
- Guidance of $1.20–1.30 billion for Q3 sits below the June record, so tool orders arrive in waves around each capacity milestone.
- Over one to three years, AI compute and memory test intensity supports volume; the risk is test-house capex pausing if NVIDIA's commitments stop compounding.
